Dr Beth Faiman discusses practical strategies for patient counseling, monitoring, and adverse event management to support long-term treatment persistence in polycythemia vera.
Dr Beth Faiman discusses practical strategies for patient counseling, monitoring, and adverse event management to support long-term treatment persistence in polycythemia vera.
Dr Rami Komrokji reviews long-term efficacy and safety data in polycythemia vera, highlighting durability of response, phlebotomy reduction, and sustained disease control.
Dr Rami Komrokji reviews long-term efficacy and safety data in polycythemia vera, highlighting durability of response, phlebotomy reduction, and sustained disease control.
Dr Thomas LeBlanc examines long-term clinical trial data evaluating durable hematologic control and disease outcomes in patients with polycythemia vera.
Dr Thomas LeBlanc examines long-term clinical trial data evaluating durable hematologic control and disease outcomes in patients with polycythemia vera.